Have healthcare stocks been pushed too high?

Sonic's slower growth might make it overpriced

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Sonic Healthcare Limited (ASX: SHL) has announced its full year's result today, reporting a 7% increase in full year net profit to $316 million, on revenues of $3.3 billion.

Cash flow from operations was strong, coming in at $487 million, a 19% rise over last year. The company declared a final dividend of 35 cents, the same as last year's. The total dividend for the year was 59 cents, partly franked to 28%.

The company's medical centres division had the biggest jump in revenues, rising 35%, while the pathology division also posted strong growth – apart from New Zealand, which was down 6%.

Revenues were also driven by a multitude of acquisitions globally, although the strong Australian dollar had the effect of reducing the revenue number by $77m in constant currency terms, compared to 2011.

Total debt increased slightly to $1.7 billion, related to acquisitions mentioned above.

Health care sector stocks have been in focus since the beginning of the year, as they are usually insulated from offshore events, such as the European debt crisis, although some companies like Ramsay Health Care (ASX: RHC) operate private hospitals in countries like Indonesia, France and the UK. That hasn't stopped shares in Ramsay rising 26% since the start of the year, compared to the S&P / ASX 200 index, which has risen just 7.8%.

Sonic's pathology competitor, Primary Health Care Limited (ASX: PRY) is more focused in Australia and is trading just below 52-week highs of $3.61, mainly thanks to strong demand for health care stocks. Even Sigma Pharmaceutical Limited (ASX: SIP) has seen its shares in demand, rising 21% since the beginning of this year, despite risks to the company from reforms to the Pharmaceutical Benefits Scheme (PBS).

Getting to the outlook for the 2013 year, Sonic expects to grow earnings before interest, tax, depreciation and amortisation (EBITDA) by 5 to 10% over the 2012 level of $624m, on a constant currency basis.

The Foolish bottom line

Another solid result from a solid performer, although earnings per share growth have been harder to come by over the last 5 years, averaging just 8%. By comparison, revenues have grown by an average of 13%. Over the last 10 years, Sonic had average earnings per share growth of 22%, which suggests that Sonic's fast growth phase is over, and it's now in a slower growth mode. Trading on a trailing P/E ratio of over 16, it appears slightly expensive.

If you're in the market for some high yielding ASX shares, look no further than our "Secure Your Future with 3 Rock-Solid Dividend Stocks" report. In this free report, we've put together our best ideas for investors who are looking for solid companies with high dividends and good growth potential. Click here now to find out the names of our three favourite income ideas. But hurry – the report is free for only a limited time.

More reading

Motley Fool writer/analyst Mike King doesn't own shares in any companies mentioned. The Motley Fool's purpose is to help the world invest, better. Take Stock is The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Click here now to request your free subscription, whilst it's still available. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »